Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai InnoStar Bio-tech CoSHSE:688710 +0.56%35 PS Ratio is 12.81 as of Jul. 29, 2026, which is 112% above its 10-year median of 6.04. GuruFocus rates SHSE:688710 with a GF Score™ of 35/100. The stock has 12 warning signs investors should review. Among 953 Drug Manufacturers companies, Shanghai InnoStar Bio-tech Co ranks worse than 90.66% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Shanghai InnoStar Bio-tech Co's share price is ¥77.90.
Shanghai InnoStar Bio-tech Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ¥6.08. Hence, Shanghai InnoStar Bio-tech Co's PS Ratio for today is 12.81.
Warning Sign:
Shanghai InnoStar Bio-tech Co Ltd stock PS Ratio (=12.65) is close to 2-year high of 12.81.
The historical rank and industry rank for Shanghai InnoStar Bio-tech Co's PS Ratio or its related term are showing as below:
SHSE:688710'
s PS Ratio Range Over the Past 10 Years
Min: 2.22 Med: 6.04 Max: 13.1
Current: 12.8
During the past 7 years, Shanghai InnoStar Bio-tech Co's highest PS Ratio was 13.10. The lowest was 2.22. And the median was 6.04.
SHSE:688710's PS Ratio is ranked worse than 90.66% of 953
companies
in the Drug Manufacturers industry
Industry Median: 2.28
vs SHSE:688710: 12.80
During the past 7 years, Shanghai InnoStar Bio-tech Co's highest 3-Year average Revenue per Share Growth Rate was 29.30% per year. The lowest was -13.10% per year. And the median was 13.75% per year.
Back to Basics: PS Ratio
Shanghai InnoStar Bio-tech Co (SHSE:688710) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Shanghai InnoStar Bio-tech Co PS Ratio Related Terms
Shanghai InnoStar Bio-tech Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688710 vs LLY, JNJ, ABBV: PS Ratio Comparison
For the Drug Manufacturers - General subindustry, Shanghai InnoStar Bio-tech Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai InnoStar Bio-tech Co PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai InnoStar Bio-tech Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Shanghai InnoStar Bio-tech Co's PS Ratio falls into.
Shanghai InnoStar Bio-tech Co PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Shanghai InnoStar Bio-tech Co's Share Price of today is ¥77.90. Shanghai InnoStar Bio-tech Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥6.08.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Shanghai InnoStar Bio-tech Co (SHSE:688710) has a PS Ratio of 12.81 as of Jul. 29, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Shanghai InnoStar Bio-tech Co and its competitors. This is 112% above median its historical median of 6.04. Over the past decade, Shanghai InnoStar Bio-tech Co's PS Ratio has ranged from 2.22 to 13.10. According to the industry distribution chart, Shanghai InnoStar Bio-tech Co ranks #864 out of 953 companies in the Drug Manufacturers industry, placing it in the top 90.7%.
Is Shanghai InnoStar Bio-tech Co's PS Ratio too high?
Shanghai InnoStar Bio-tech Co's current PS Ratio of 12.81 is 112% above median its 10-year median of 6.04. Over the past 10 years, this metric has ranged from a low of 2.22 to a high of 13.10. The Drug Manufacturers industry median PS Ratio is 2.28. Shanghai InnoStar Bio-tech Co's value of 12.81 is 461.8% above this industry median. Based on the distribution chart, Shanghai InnoStar Bio-tech Co ranks #864 out of 953 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Shanghai InnoStar Bio-tech Co has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai InnoStar Bio-tech Co's PS Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Shanghai InnoStar Bio-tech Co ranks #864 out of 953 companies for PS Ratio. This places Shanghai InnoStar Bio-tech Co in the lower half of its industry. The industry median PS Ratio is 2.28. Shanghai InnoStar Bio-tech Co's value of 12.81 is 461.8% above this benchmark. Historically, Shanghai InnoStar Bio-tech Co's own PS Ratio has ranged from 2.22 to 13.10 over the past decade. While the company's 10-year median is 6.04 vs. the industry median of 2.28, Shanghai InnoStar Bio-tech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.28, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai InnoStar Bio-tech Co's current PS Ratio of 12.81 is 461.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Shanghai InnoStar Bio-tech Co and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai InnoStar Bio-tech Co's current PS Ratio is 12.81, which is 112% above median its own 10-year median of 6.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai InnoStar Bio-tech Co stock overvalued right now?
Shanghai InnoStar Bio-tech Co (SHSE:688710) has a current PS Ratio of 12.81. The current PS Ratio is 12.81, which is 112% above median its 10-year median of 6.04 and 461.8% above the Drug Manufacturers industry median of 2.28. Shanghai InnoStar Bio-tech Co's overall GF Score™ is 35/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Shanghai InnoStar Bio-tech Co (SHSE:688710), the current PS Ratio is 12.81 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shanghai InnoStar Bio-tech Co Business Description
Shanghai InnoStar Bio-tech Co Ltd is a comprehensive research and development services (CRO) enterprise that specializes in providing biomedical non-clinical research services.
35GF Score
Get the complete analysis for SHSE:688710
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688710 has been successfully added to your 
